Scientists and health officials around the world are keeping their eyes on a descendant of the omicron variant that has been found in more than 50 countries, including the United States.
Jan 26, 2022
0
23
For some people, the COVID-19 pandemic has brought about change—some welcome and some not so welcome—to their routines or to what they prioritize. We asked four scholars to reflect on a health habit that they have adopted ...
Jan 12, 2022
0
12
Linguist Susanne Brouwer and a group of her students conducted three experiments to see how well people understand each other when music is playing in the background. For this study, she used a selection of Katy Perry songs, ...
Aug 3, 2021
0
1
A new variant of SARS-CoV-2 is spreading rapidly in the United Kingdom, with over 1,400 cases since September. SARS-CoV-2, the virus that causes COVID-19, generally accumulates mutations slowly over time, but this new variant ...
Dec 23, 2020
0
3
More than a dozen drugs are known to treat symptoms such as hallucinations, erratic behaviors, disordered thinking and emotional extremes associated with schizophrenia, bipolar disorder and other severe mental illnesses. ...
Dec 3, 2020
0
19
European Union regulators fined Israeli drug-maker Teva on Thursday for colluding to delay a cheaper generic version of modafinil, a blockbuster sleep disorder drug.
Nov 26, 2020
0
4
Young Europeans are drinking less alcohol and also smoking less—but are increasingly dabbling with cannabis, a continent-wide study showed Thursday.
Nov 12, 2020
0
2
A team at the University of Luxembourg's Interdisciplinary Centre for Security, Reliability and Trust (SnT), led by SnT Vice-Director Yves Le Traon, has developed an online tool to simulate COVID-19 exit strategy planning ...
May 26, 2020
0
1
The cost of prescriptions for multiple sclerosis (MS) drugs nearly tripled over seven years, and the introduction of a generic version of one of the most common drugs had little overall effect on prices, according to a study ...
Jan 15, 2020
0
1
Discount cards for brand-name drugs provided to patients increased private insurer costs by 46% and varied in their impact on out-of-pocket payments by patients, found new research in CMAJ (Canadian Medical Association Journal).
Nov 11, 2019
0
1
